Travere Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 10.60 M | $253.31 M | 11.09% | 11.92% |
| BLACKROCK, INC. | 11/12/2025 | 8.10 M | $193.60 M | -0.84% | 9.11% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 6.72 M | $160.70 M | -24.25% | 7.56% |
| VANGUARD GROUP INC | 11/07/2025 | 6.61 M | $158.06 M | 10.33% | 7.44% |
| MACQUARIE GROUP LTD | 11/13/2025 | 4.98 M | $119.13 M | -2.22% | 5.60% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 3.79 M | $90.69 M | 354.85% | 4.27% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 3.55 M | $84.89 M | 27.59% | 3.99% |
| STATE STREET CORP | 11/14/2025 | 3.22 M | $76.91 M | -7.62% | 3.62% |
| FMR LLC | 11/13/2025 | 2.89 M | $69.17 M | 171.05% | 3.25% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 2.16 M | $51.74 M | 13.45% | 2.43% |
| EMERALD ADVISERS, LLC | 10/30/2025 | 2.15 M | $51.31 M | 2.65% | 2.41% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.14 M | $51.11 M | 6.70% | 2.40% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.75 M | $41.88 M | -29.78% | 1.97% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 10/28/2025 | 1.60 M | $38.23 M | 100.00% | 1.80% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.60 M | $38.22 M | 209.61% | 1.80% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 1.42 M | $33.87 M | 7.77% | 1.59% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.40 M | $33.43 M | -13.72% | 1.57% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.27 M | $30.45 M | -18.17% | 1.43% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 1.20 M | $28.72 M | 3,331.89% | 1.35% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/30/2025 | 1.20 M | $28.70 M | 5.21% | 1.35% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 1.15 M | $27.49 M | 0.00% | 1.29% |
| MORGAN STANLEY | 11/14/2025 | 1.12 M | $26.70 M | -28.79% | 1.26% |
| JENNISON ASSOCIATES LLC | 10/30/2025 | 1.08 M | $25.92 M | 40.55% | 1.22% |
| NUVEEN, LLC | 11/12/2025 | 1.08 M | $25.78 M | -9.68% | 1.21% |
| ABRDN PLC | 11/07/2025 | 967.39 K | $23.12 M | 7.90% | 1.09% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 949.73 K | $22.70 M | -38.36% | 1.07% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 929.00 K | $22.20 M | 1.12% | 1.04% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 883.67 K | $21.12 M | 18.67% | 0.99% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 857.90 K | $20.50 M | 25.15% | 0.96% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 852.20 K | $20.37 M | -0.77% | 0.96% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 848.36 K | $20.28 M | 9.99% | 0.95% |
| NORTHERN TRUST CORP | 11/14/2025 | 832.08 K | $19.89 M | 3.93% | 0.94% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 707.46 K | $16.91 M | 100.00% | 0.80% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 700.00 K | $16.73 M | 0.00% | 0.79% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 696.70 K | $16.65 M | -34.13% | 0.78% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 684.38 K | $16.45 M | 14.89% | 0.77% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 663.25 K | $15.85 M | -41.34% | 0.75% |
| INVESCO LTD. | 11/13/2025 | 627.90 K | $15.01 M | 22.90% | 0.71% |
| MARSHALL WACE, LLP | 11/13/2025 | 590.05 K | $14.10 M | -20.56% | 0.66% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 575.40 K | $13.75 M | 132.58% | 0.65% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 572.00 K | $13.67 M | -5.32% | 0.64% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 569.70 K | $13.62 M | 31.87% | 0.64% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 565.60 K | $13.52 M | 223.14% | 0.64% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 520.59 K | $12.44 M | 1.99% | 0.59% |
| CANDRIAM S.C.A. | 11/06/2025 | 512.68 K | $12.25 M | 0.00% | 0.58% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 500.00 K | $11.95 M | -48.45% | 0.56% |
| JPMORGAN CHASE & CO | 11/26/2025 | 493.84 K | $11.80 M | -36.02% | 0.56% |
| UBS GROUP AG | 11/13/2025 | 493.07 K | $11.78 M | -24.18% | 0.55% |
| IMPAX ASSET MANAGEMENT GROUP PLC | 11/06/2025 | 475.00 K | $11.35 M | 0.00% | 0.53% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 467.00 K | $11.16 M | 100.00% | 0.53% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Travere Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 288 institutional investors and hedge funds held shares of Travere Therapeutics, Inc.. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 10.6 M
BlackRock, Inc.: 8.1 M
ARMISTICE CAPITAL, LLC: 6.72 M
VANGUARD GROUP INC: 6.61 M
MACQUARIE GROUP LTD: 4.98 M
PERCEPTIVE ADVISORS LLC: 3.79 M
113.24% of Travere Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 113.04 M shares in the last 24 months. This purchase volume represents approximately $2.79 B in transactions.